Skip to Main Content

Paper Details

Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer.
Cancer Discov
17
2021
-, Cancer, Cas9, MYCN, NXF1, NXT1, NXT2, NXT2 paralog, cancer, cancer cell lines, mRNA, neuroblastoma, tumor, tumor cells
Author NameAffiliation
Guillaume KugenerBroad Institute of MIT and Harvard
Brenton R PaolellaBroad Institute of MIT and Harvard
Joseph D ManciasDana-Farber Cancer Institute
David E RootBroad Institute of MIT and Harvard
David E RootBroad Institute of MIT and Harvard
Todd R GolubDana-Farber Cancer Institute
Todd R GolubBoston Children's Hospital
Todd R GolubHarvard Medical School
Todd R GolubBroad Institute of MIT and Harvard
Todd R GolubDana-Farber Cancer Institute
Todd R GolubBroad Institute of MIT and Harvard
Todd R GolubHarvard Medical School
Todd R GolubBoston Children's Hospital
Francisca VazquezBroad Institute of MIT and Harvard
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBroad Institute of MIT and Harvard
Kimberly StegmaierHarvard Medical School
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBroad Institute of MIT and Harvard
Kimberly StegmaierHarvard Medical School
Kimberly StegmaierBoston Children's Hospital
  • 1 - 22

Datasets